Literature DB >> 19773294

Platelet factor 4 (CXCL4) facilitates human macrophage infection with HIV-1 and potentiates virus replication.

Franziska Schwartzkopff1, Tobias A Grimm, Carla S R Lankford, Karen Fields, Jiun Wang, Ernst Brandt, Kathleen A Clouse.   

Abstract

Platelet factor 4 (CXCL4), a member of the CXC chemokine subfamily released in high amounts by activated platelets, has been identified as a monocyte survival factor that induces monocyte differentiation into macrophages. Although CXCL4 has been shown to have biological effects unique to chemokines, nothing is known about the role of CXCL4-derived human macrophages or CXCL4 in human immunodeficiency virus (HIV) disease. In this study, CXCL4-derived macrophages are compared with macrophage-colony stimulating factor (M-CSF)-derived macrophages for their ability to support HIV-1 replication. We show that CXCL4-derived macrophages can be infected with macrophage-tropic HIV-1 that uses either CC-chemokine receptor 5 (CCR5) or CXC-chemokine receptor 4 (CXCR4) as a co-receptor for viral entry. We also find that M-CSF and the chemokines, monocyte chemoattractant protein 1 (MCP-1; CCL2) and macrophage-inflammatory-protein-1-alpha (MIP-1alpha; CCL3) are produced upon R5- and X4-tropic HIV-1 replication in both M-CSF- and CXCL4-derived human macrophages. In addition, CXCL4 added to M-CSF-derived macrophages after virus adsorption and maintained throughout the infection enhances HIV-1 replication. We thus propose a novel role for CXCL4 in HIV disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19773294     DOI: 10.1177/1753425909106171

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  13 in total

1.  Alternative C-terminal helix orientation alters chemokine function: structure of the anti-angiogenic chemokine, CXCL4L1.

Authors:  Je-Hung Kuo; Ya-Ping Chen; Jai-Shin Liu; Alexandre Dubrac; Cathy Quemener; Hervé Prats; Andreas Bikfalvi; Wen-guey Wu; Shih-Che Sue
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

2.  Chemokine PF4 Inhibits EV71 and CA16 Infections at the Entry Stage.

Authors:  Zhichao Pei; Hong Wang; Zhilei Zhao; Xiang Chen; Chen Huan; Wenyan Zhang
Journal:  J Virol       Date:  2022-05-17       Impact factor: 6.549

3.  TGFβ-Mediated Downregulation of Thrombopoietin Is Associated With Platelet Decline in Asymptomatic SIV Infection.

Authors:  Kelly A Metcalf Pate; Claire E Lyons; Jamie L Dorsey; Suzanne E Queen; Robert J Adams; Craig N Morrell; Joseph L Mankowski
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

4.  Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral Attachment.

Authors:  Zahra F Parker; Ann H Rux; Amber M Riblett; Fang-Hua Lee; Lubica Rauova; Douglas B Cines; Mortimer Poncz; Bruce S Sachais; Robert W Doms
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-15       Impact factor: 2.205

5.  HIV and SIV Associated Thrombocytopenia: An Expanding Role for Platelets in the Pathogenesis of HIV.

Authors:  Kelly A Metcalf Pate; Joseph L Mankowski
Journal:  Drug Discov Today Dis Mech       Date:  2011-11-09

Review 6.  Platelets and infection - an emerging role of platelets in viral infection.

Authors:  Alice Assinger
Journal:  Front Immunol       Date:  2014-12-18       Impact factor: 7.561

7.  Modeling HIV-1 Induced Neuroinflammation in Mice: Role of Platelets in Mediating Blood-Brain Barrier Dysfunction.

Authors:  Letitia D Jones; Joseph W Jackson; Sanjay B Maggirwar
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

8.  Platelet activation suppresses HIV-1 infection of T cells.

Authors:  Theodros Solomon Tsegaye; Kerstin Gnirß; Niels Rahe-Meyer; Miriam Kiene; Annika Krämer-Kühl; Georg Behrens; Jan Münch; Stefan Pöhlmann
Journal:  Retrovirology       Date:  2013-05-01       Impact factor: 4.602

Review 9.  Human platelets and their capacity of binding viruses: meaning and challenges?

Authors:  Adrien Chabert; Hind Hamzeh-Cognasse; Bruno Pozzetto; Fabrice Cognasse; Mirta Schattner; Ricardo M Gomez; Olivier Garraud
Journal:  BMC Immunol       Date:  2015-04-28       Impact factor: 3.615

10.  Serum amyloid A1 in combination with integrin αVβ3 increases glioblastoma cells mobility and progression.

Authors:  Ching-Yu Lin; Shun-Tai Yang; Shing-Chuan Shen; Yi-Chen Hsieh; Fei-Ting Hsu; Cheng-Yu Chen; Yung-Hsiao Chiang; Jian-Ying Chuang; Kai-Yun Chen; Tsung-I Hsu; Wan-Chong Leong; Yu-Kai Su; Wei-Lun Lo; Yi-Shian Yeh; Yudha Nur Patria; Hsiu-Ming Shih; Che-Chang Chang; Szu-Yi Chou
Journal:  Mol Oncol       Date:  2018-04-17       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.